Chronic urticaria: Impact of allergic inflammation

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 57, Issue 75, 2002, Pages 19-24

  Hein, Ruediger ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Classification; Desloratadine; Diagnosis; Etiology; Histamine H1 receptor antagonists; Quality of life; Therapeutics; Urticaria

Indexed keywords

ALIMEMAZINE; CLEMASTINE; CYPROHEPTADINE; DESLORATADINE; DOXYLAMINE; GLUCOCORTICOID; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; KETOTIFEN; PHENIRAMINE; PROMETHAZINE;

ADOLESCENT; ADULT; ALLERGY; ARTICLE; CHRONIC URTICARIA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

CHRONIC DISEASE; DERMATITIS, ALLERGIC CONTACT; DIAGNOSIS, DIFFERENTIAL; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPNOTICS AND SEDATIVES; URTICARIA;

EID: 0036971720     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. RING J, BROCKOW K, OLLERT M, ENGST R. Antihistamines in urticaria. Clin Exp Allergy 1999;29(Suppl. 1):31-37.
2. O'DONNELL BF, LAWLOR F, SIMPSON J, MORGAN M, GREAVES MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997;136:197-201.
3. POON E, SEED PT, GREAVES MW, KOBZA-BLACK A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999;140:667-671.
4. THOMPSON AK, FINN AF, SCHOENWETTER WF. Effect of 60 mg twice-daily fexofenadine HCL on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. J Am Acad Dermatol 2000;43:24-30.
5. ZUBERBIER T, GREAVES MW, JUHLIN L, MARK H, STINGL G, HENZ BM. Management of urticaria: a consensus report. J Invest Dermatol Symp Proc 2001;6:128-131.
6. GEHA RS, MELTZER EO. Desloratadine: a new, nonsedating, oral antihistamine. J Allergy Clin Immunol 2001;107:751-762.
7. BACHERT C. Therapeutic points of intervention and clinical implications: role of desloratadine. Clin Exp Immunol 2002 (in press).
8. MÜNSTER I, PLEYL-WISGIKI G, TRAIDL-HOFFMANN C, RING J, BEHRENDT H. Desloratadine regulates the expression of MHC-class molecules and costimulatory signals in cultured human keratinocytes. Allergy 2002;57(Suppl. 73):307-308.
9. REUTHER T, WILLIAMS SC, KERSCHER M. Anti-inflammatory activity of desloratadine: a pilot study. Poster abstract presented at 20th World Congress of Dermatology, 4-5 July 2002, Paris, France.
10. WUTHRICH B. Food-induced cutaneous adverse reactions. Allergy 1998;53(Suppl. 46): 131-135.
11. SHIPLEY D, ORMEROD AD. Drug-induced urticaria. Recognition and treatment. Am J Clin Dermatol 2001;2:151-158.
12. COUSIN F, PHILIPS K, FAVIER B, BIENVENU J, NICOLAS JF. Drug-induced urticaria. Eur J Dermatol 2001;11:181-187.
13. BARLOW RJ, WARBURTON F, WATSON K, BLACK AK, GREAVES MW. Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria. J Am Acad Dermatol 1993;29:954-958.
14. GREAVES M. Chronic urticaria. J Allergy Clin Immunol 2000;105:664-672.
15. MONFRECOLA G, MASTURZO E, RICCARDO AM, BALATO F, AYALA F, DI COSTANZO MP. Solar urticaria: a report on 57 cases. Am J Contact Dermatol 2000;11:89-94.
16. LUONG KV, NGUYEN LT. Aquagenic urticaria: report of a case and review of the literature. Ann Allergy Asthma Immunol 1998;80:483-485.
17. WAKELIN SH. Contact urticaria. Clin Exp Dermatol 2001;26:132-136.
18. NZEAKO UC, FRIGAS E, TREMAINE WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med 2001;161:2417-2429.
19. VALENT P, HORNY HP, ESCRIBANO L et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001;25:603-625.
20. SABROE RA, GRATTAN CE, FRANCIS DM, BARR RM, KOBZA BLACK A, GREAVES MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999;140:446-452.
21. RYHAL B, DEMERA RS, CHOENFELD Y, PETER JB, GERSHWIN ME. Are autoantibodies present in patients with subacute and chronic urticaria? J Invest Clin Immunol 2001;11:16-20.
22. SABROE RA, SEED PT, FRANCIS DM, BARR RM, BLACK AK, GREAVES MW. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FeRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999;40:443-450.
23. GRATTAN C, BOON AP, EADY RA, WINKELMANN RK. The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions. Int Arch Allergy Appl Immunol 1990;93:198-204.
24. GAIG P, GARCIA-ORTEGA P, ENRIQUE E, RICHART C. Successful treatment of chronic idiopathic urticaria associated with thyroid autoimmunity. J Invest Allergol Clin Immunol 2000;10:342-345.
25. ZAULI D, DELEONARID G, GODERARO S et al. Thyroid autoimmunity in chronic urticaria. Allergy Asthma Proc 2001;22:93-95.
26. JOINT TASK FORCE ON PRACTICE PARAMETERS. The diagnosis and management of urticaria: a practice parameter. Part I. Acute urticaria/angioedema. Part II. Chronic urticaria/angioedema. Ann Allergy Asthma Immunol 2000;85:521-544.
27. SANCHEZ NP, WINKELMANN RK, SCHROETER AL et al. The clinical and histopathologic spectrums of urticarial vasculitis: study of forty cases. J Am Acad Dermatol 1982;7:599-605.
28. MEHREGAN DR, HALL MJ, GIBSON LE. Urticarial vasculitis. A histopathologic and clinical review of 72 cases. J Am Acad Dermatol 1992;26:441-448.
29. LEE EE, MAIBACH HI. Treatment of urticaria. An evidence-based evaluation of antihistamines. Am J Clin Dermatol 2001;2:27-32.
30. CAMPOLI-RICHARDS DM, BUCKLEY MM, FITTON A. Cetirizone. A review of its pharmacologic properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Drugs 1990;40:762-781.
31. RING J, HEIN R, GAUGER A, BRONSKY E, MILLER B. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Int J Dermatol 2001;40:72-76.
32. 2-receptors in cutaneous inflammation in the guinea-pig produced by histamine and mast cell degranulation. Br J Pharmacol 1980;69(Suppl. 23):615-623.
33. GREAVES MW, DAVIES MG. Histamine receptors in human skin: indirect evidence. Br J Dermatol 1982;107:101-105.
34. 2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR mice. Eur J Pharmacol 1999;367:361-371.
35. GRATTAN C, O'DONNELL BF, FRANCIS DM et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 2000;143:365-372.
36. O'DONNELL BF, BARR RM, BLACK AK et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998;138:101-106.